Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

US brand protection and authentication specialist Ennoventure ... fast-moving consumer good (FMCG), automotive and industrial ...

Shares of Hikma Pharmaceuticals PLC HIK slipped 2.64% to £17.72 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index UKX falling 0.07% ...

Every pharmaceutical marketer wants their brand campaign to be more emotional, but do we know why emotional marketing is important for brand adoption? To help you answer this question, this ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Out-of-home posters using the term “HER2.0” showed that the drug could also be used to fight gastrointestinal cancers.

Murphy said Marra’s “breadth of global brand commercialization and pharmaceutical product expertise will give Havas Health a ...

Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...